NasdaqGM:TARA
NasdaqGM:TARABiotechs

Protara Therapeutics (TARA): Evaluating Valuation Following S&P Global BMI Index Inclusion

Protara Therapeutics (TARA) just got a boost of attention by being added to the S&P Global BMI Index. For investors, this type of milestone often signals a shift in profile, drawing more eyes from institutions and fund managers who track major indices. Index addition does not guarantee major price moves, but it can influence sentiment, making some take another look at stocks that were previously flying under the radar. This index news arrives after a year of change for Protara Therapeutics...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

How Recent NBA Franchise Sales Could Impact Atlanta Braves Holdings Stock in 2025

Trying to decide what to do with Atlanta Braves Holdings stock? You are definitely not alone. Even the most seasoned investors are giving this one a hard look, especially as the backdrop for all sports ownership seems to be shifting. The stock has been anything but boring lately, with a recent dip of 0.8% over the past week and a larger drop of 8.4% over the last month. Zoom out just a little, and the picture brightens: the year-to-date return is still a positive 9.4%, and over the past three...
NasdaqGS:PPBI
NasdaqGS:PPBIBanks

The Bull Case For Pacific Premier Bancorp (PPBI) Could Change Following Voluntary SEC Deregistration Filing

Pacific Premier Bancorp, Inc. recently filed a Form 15 with the SEC to voluntarily deregister its common stock under the Securities Exchange Act of 1934, marking a major shift in its regulatory status. This voluntary deregistration is a pivotal step that typically precedes delisting from a national exchange and signals substantial changes for shareholders and market observers. We'll examine how Pacific Premier's move to voluntarily deregister its shares may reshape the company's investment...
NYSE:KBH
NYSE:KBHConsumer Durables

Has KB Home Pulled Back Too Far After Its Recent 26% Drop?

Trying to figure out whether now is the right time to make a move with KB Home stock? You are definitely not alone. After a stellar run over the last few years, with shares leaping a whopping 157.5% over the past three years and nearly doubling over five, KB Home has hit a bit of a cooling period. Year to date, the stock has dipped by 1.1% and is down 1.9% just in the last week. Even looking back a full year, the stock has retreated by 26.3%, which is a significant reversal. This has many...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

Buybacks and Special Dividends Might Change the Case for Investing in International General Insurance (IGIC)

International General Insurance Holdings has recently attracted renewed investor interest following its share repurchase activity and announcement of special dividend payouts, demonstrating a focus on capital returns to shareholders. This increased emphasis on returning capital, combined with an attractive price-to-book valuation relative to peers, highlights management’s shareholder-oriented approach and commitment to disciplined capital allocation. To understand the broader impact, we'll...
NasdaqGS:WBA
NasdaqGS:WBAConsumer Retailing

Does Walgreens Boots Alliance's (WBA) SEC Deregistration Plan Signal a Shift in Investor Engagement?

Earlier this month, Walgreens Boots Alliance announced it had filed a Form 15 with the SEC to voluntarily deregister its Common Stock, affecting its compliance with the Securities Exchange Act of 1934. This voluntary deregistration is an unusual step for a major public company and could have significant consequences for its trading status and how investors engage with the stock. We'll now explore how the voluntary deregistration announcement could influence Walgreens Boots Alliance's...
NasdaqGS:AKRO
NasdaqGS:AKROBiotechs

Will Legal Scrutiny of Akero Therapeutics (AKRO) Leadership Reshape Confidence in Its Long-Term Strategy?

In recent news, Kahn Swick & Foti, LLC initiated an investigation into potential breaches of fiduciary duty or law violations by Akero Therapeutics officers or directors after the company's lead drug candidate efruxifermin did not meet primary endpoints in its Phase 2b SYMMETRY trial. This investigation follows the company's disclosure of class action lawsuits, increasing legal uncertainty for stakeholders and signaling a pivotal moment for corporate governance. We'll explore how the...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Latest News In Digital Payment - Driving Growth With Real-Time And Recurring Payment Innovations

A recent study by Juniper Research highlights significant growth prospects in the digital payment space, with global Account-to-Account (A2A) payment transaction values projected to rise by 113% over the next five years, reaching $195 trillion by 2030. This growth is being driven by the implementation of real-time payment systems, which are expected to facilitate new payment use cases like instant payroll and real-time bill settlements. Enhanced data sharing in real-time payments is also...
NasdaqGM:CERS
NasdaqGM:CERSMedical Equipment

September 2025 Undervalued Small Caps With Insider Activity Across Regions

As of September 2025, the U.S. stock market has been reaching new heights, with major indices like the S&P 500 and Nasdaq posting consistent gains over recent weeks. While large-cap stocks have captured much of the spotlight, small-cap stocks are also drawing attention as the Russell 2000 index hit a record high before a slight pullback. In this environment, identifying opportunities in small-cap companies can be appealing due to their potential for growth and responsiveness to economic...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Discover 3 Stocks That Might Be Trading Below Their Estimated Fair Value

As U.S. stock indexes reach new highs, with the S&P 500 and Nasdaq posting their third consecutive week of gains, investors are increasingly focused on identifying opportunities that might be trading below their estimated fair value. In this buoyant market environment, a good stock is often characterized by strong fundamentals and potential for growth that isn't fully reflected in its current price.
NasdaqGM:CHRS
NasdaqGM:CHRSBiotechs

3 Promising Penny Stocks With Market Caps At Least $100M

Major stock indexes in the United States have recently reached new highs, with the S&P 500 and Nasdaq Composite posting their third consecutive week of gains. In this thriving market landscape, investors often look beyond established giants to uncover hidden gems that might offer unique growth opportunities. Penny stocks, though sometimes seen as a relic of past market eras, continue to represent potential for significant returns when they come from smaller or newer companies with strong...
NYSE:EBF
NYSE:EBFCommercial Services

Fulton Financial And 2 Other Leading Dividend Stocks To Consider

As the U.S. stock market reaches new highs with the S&P 500 and Nasdaq posting a third consecutive week of gains, investors are keenly observing opportunities that align with these positive trends. In such an environment, dividend stocks can offer a compelling blend of income and potential capital appreciation, making them an attractive consideration for those looking to benefit from both market momentum and steady returns.